Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypoxia × Genitourinary × Clear all

Phase

Phase 1/2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 15 Other hematologic neoplasm 4 Head & Neck 4 Lymphoid 2 Gynecologic 2 Sarcoma 1 Other 1 Genitourinary 1 CNS 1

Conditions

Prostatic Neoplasms 1572 Urinary Bladder Neoplasms 320 Breast Neoplasms 185 Carcinoma, Renal Cell 182 Neoplasms 151 Kidney Neoplasms 138 Lung Neoplasms 91 Colorectal Neoplasms 85 Motor Activity 76 Testicular Neoplasms 49 Ovarian Neoplasms 42 Melanoma 42 Neoplasm Metastasis 39 Colonic Neoplasms 39 Non-Muscle Invasive Bladder Neoplasms 38 Urinary Incontinence 37 Uterine Cervical Neoplasms 35 Sarcoma 34 Pancreatic Neoplasms 34 Disease 34 Carcinoma, Transitional Cell 34 Head and Neck Neoplasms 33 Recurrence 30 Urologic Neoplasms 29 Lymphoma 27 Anxiety Disorders 26 Endometrial Neoplasms 25 Stomach Neoplasms 23 Prostatic Hyperplasia 23 Multiple Myeloma 23

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03365076 2023-01-09

EXIPOX

University Hospital of North Norway

Phase NA Terminated

Hypoxia, Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡